Not applicableUnknownNCT06524557What this trial is testingExploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver TumorsWho this might be right forLiver Tumor Xijing Hospital 200
Testing effectiveness (Phase 2)UnknownNCT02638857What this trial is testingImmunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular CarcinomaWho this might be right forRecurrence Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma Second Military Medical University 60
Testing effectiveness (Phase 2)Study completedNCT04710641What this trial is testingRadomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib AloneWho this might be right forHepatocellular CarcinomaHepatitis BHepatitis C Mina Alpha Limited 8
Not applicableUnknownNCT01957241What this trial is testingPLA for HCC and Esophageal ca SerumWho this might be right forHepatocellular CarcinomaEsophageal Cancer National Taiwan University Hospital 164
Not applicableLooking for participantsNCT06486454What this trial is testingReal-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)Who this might be right forLiver NeoplasmsPrimary Liver CancerSecondary Liver Cancer+2 more HistoSonics, Inc. 5,000
Testing effectiveness (Phase 2)UnknownNCT03825705What this trial is testingA Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular CarcinomaWho this might be right forAdvanced Biliary Adenocarcinoma/Hepatocellular Carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT01545141What this trial is testingChemokine-Modulatory Regimen for Recurrent Resectable Colorectal CancerWho this might be right forColorectal CancerColorectal CarcinomaColorectal Tumors+1 more Roswell Park Cancer Institute 15
Not applicableLooking for participantsNCT05713994What this trial is testingCombined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Non-resectable Ze-yang Ding, MD 300
Not applicableStudy completedNCT03564405What this trial is testingPilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Non-resectable Jeil Pharmaceutical Co., Ltd. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078305What this trial is testingComparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line TreatmentWho this might be right forHepatocellular Carcinoma Tianjin Medical University Cancer Institute and Hospital 134
Not applicableLooking for participantsNCT05661786What this trial is testingClinical Outcomes of HBeAg-negative CHB Patients With Indeterminate PhaseWho this might be right forChronic Hepatitis b The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 4,500
Early research (Phase 1)Study completedNCT01129570What this trial is testingSiliphos in Advanced Hepatocellular CarcinomaWho this might be right forAdvanced Hepatocellular Carcinoma Abby Siegel 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT06779461What this trial is testingA Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Non-Resectable InnoBM Pharmaceuticals Co., Ltd. 228
Testing effectiveness (Phase 2)Looking for participantsNCT07047586What this trial is testingLenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and BevacizumabWho this might be right forHepatocellular Carcinoma (HCC) Fudan University 146
Testing effectiveness (Phase 2)Study completedNCT03586973What this trial is testingCabozantinib in Japanese Participants With Advanced Hepatocellular CarcinomaWho this might be right forAdvanced Hepatocellular Carcinoma Takeda 34
Not applicableStudy completedNCT01361061What this trial is testingAFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the LiverWho this might be right forLiver Cirrhosis University Hospital Freiburg 450
Not applicableLooking for participantsNCT05887661What this trial is testingGoal-directed LCVP Based on HP in Laparoscopic HepatectomyWho this might be right forHepatocellular Carcinoma The First Affiliated Hospital with Nanjing Medical University 100
Post-approval studies (Phase 4)UnknownNCT01570075What this trial is testingRadiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan CriteriaWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 180
Not applicableUnknownNCT04813432What this trial is testingMultiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and PancreasWho this might be right forContrast MediaComputed TomographyImaging+2 more Karolinska Institutet 50
Not applicableLooking for participantsNCT06550921What this trial is testingAblation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular CarcinomaWho this might be right forAdvanced Hepatocellular CarcinomaOligometastasisAblation+2 more Sun Yat-sen University 60